CL
The startup develops intensive drug therapies targeting age-related diseases through advanced drug discovery techniques and comprehensive support services. By focusing on extending human lifespan, the company aims to provide effective treatments that enhance health and longevity.
Updated 3 months ago
Funding
$160.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops intensive drug therapies targeting age-related diseases through advanced drug discovery techniques and comprehensive support services. By focusing on extending human lifespan, the company aims to provide effective treatments that enhance health and longevity.